These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1475080)

  • 1. [Changes in Contrast Sensitivity after Iodine Treatment in Bad Hall in Patients with Age-Related Maculopathy].
    Rieger G
    Ophthalmologica; 1992; 205(2):100-4. PubMed ID: 1475080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of combined iodine treatment in Bad Hall on the color perception of patients].
    Rieger G
    Klin Monbl Augenheilkd; 1988 Oct; 193(4):416-9. PubMed ID: 3236745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Lipoic Acid Treatment Improves Vision-Related Quality of Life in Patients with Dry Age-Related Macular Degeneration.
    Tao Y; Jiang P; Wei Y; Wang P; Sun X; Wang H
    Tohoku J Exp Med; 2016 Nov; 240(3):209-214. PubMed ID: 27840374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial.
    Bartlett HE; Eperjesi F
    Eur J Clin Nutr; 2007 Sep; 61(9):1121-7. PubMed ID: 17268417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids.
    Wolf-Schnurrbusch UE; Zinkernagel MS; Munk MR; Ebneter A; Wolf S
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8069-74. PubMed ID: 26720458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD.
    Cangemi FE
    BMC Ophthalmol; 2007 Feb; 7():3. PubMed ID: 17324285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contrast sensitivity in the fellow eye of unilateral age-related macular degeneration].
    Lu N; Zhang CF
    Zhonghua Yan Ke Za Zhi; 1992 Nov; 28(6):341-3. PubMed ID: 1306467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colour contrast sensitivity in patients with age-related Bruch's membrane changes.
    Holz FG; Gross-Jendroska M; Eckstein A; Hogg CR; Arden GB; Bird AC
    Ger J Ophthalmol; 1995 Nov; 4(6):336-41. PubMed ID: 8751098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suprathreshold contrast matching in maculopathy.
    Mei M; Leat SJ
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3419-24. PubMed ID: 17591917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration.
    Newsome DA
    Curr Eye Res; 2008 Jul; 33(7):591-8. PubMed ID: 18600492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.
    Piermarocchi S; Saviano S; Parisi V; Tedeschi M; Panozzo G; Scarpa G; Boschi G; Lo Giudice G;
    Eur J Ophthalmol; 2012; 22(2):216-25. PubMed ID: 22009916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients.
    Pedersen KB; Sjølie AK; Møller F
    Acta Ophthalmol; 2009 Nov; 87(7):714-9. PubMed ID: 19094171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postural stability and gait among older adults with age-related maculopathy.
    Wood JM; Lacherez PF; Black AA; Cole MH; Boon MY; Kerr GK
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):482-7. PubMed ID: 18791170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of dynamic processing in the visual field of patients with age-related maculopathy.
    Eisenbarth W; Mackeben M; Poggel DA; Strasburger H
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):27-37. PubMed ID: 17882447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration.
    Bansback N; Davis S; Brazier J
    Eye (Lond); 2007 Dec; 21(12):1455-63. PubMed ID: 17086167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration.
    Merry GF; Munk MR; Dotson RS; Walker MG; Devenyi RG
    Acta Ophthalmol; 2017 Jun; 95(4):e270-e277. PubMed ID: 27989012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Custom-devised and generic digital enhancement of images for people with maculopathy.
    Leat SJ; Mei M
    Ophthalmic Physiol Opt; 2009 Jul; 29(4):397-415. PubMed ID: 19292829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of visual acuity of intensely myopic patients during their eye-cure stay at Bad Hall (author's transl)].
    Rieger G
    Klin Monbl Augenheilkd; 1979 Jul; 175(1):103-6. PubMed ID: 491457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transpalpebral electrotherapy for dry age-related macular degeneration (AMD): an exploratory trial.
    Anastassiou G; Schneegans AL; Selbach M; Kremmer S
    Restor Neurol Neurosci; 2013; 31(5):571-8. PubMed ID: 23760223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.